tiprankstipranks
Trending News
More News >
Protagonist Therapeutics (PTGX)
NASDAQ:PTGX
US Market

Protagonist Therapeutics (PTGX) Cash flow

Compare
729 Followers

Protagonist Therapeutics Cash Flow

PTGX's free cash flow for Q3 2025 was $-2.02M. For the 2025 fiscal year, PTGX's free cash flow was decreased by $253.64M and operating cash flow was $-1.94M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
$ 184.15M$ -70.24M$ -108.14M$ -107.86M$ -72.48M
Investing Cash Flow
$ -299.48M$ -39.26M$ 91.47M$ -15.86M$ -90.97M
Financing Cash Flow
$ 25.85M$ 170.48M$ 18.84M$ 129.92M$ 247.63M
End Cash Position
$ 97.47M$ 186.95M$ 125.97M$ 123.89M$ 117.82M
Free Cash Flow
$ 182.80M$ -70.84M$ -108.93M$ -108.97M$ -72.95M
Currency in USD

Protagonist Therapeutics Cash Flow